Angelos M. Stergiou
CIK 1724253 · President and CEO · last filed 2025-12-05
Angelos M. Stergiou is a President and CEO who has filed 16 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for SLS, was dated Dec 5, 2025. Across all open-market trades the lifetime net is −$59.4K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.38M
2
16
-$59.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SLS | President and CEO | 686,966 | $7.83 | $5.38M | -$59.4K | 15 | 2025-12-05 |
| SELLAS Life Sciences Group, Inc. (GALE) Delisted | President and CEO | 450,135 | — | — | $0 | 1 | 2017-12-29 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-05 | SLS | Other (J) | −187,066 | -$280.6K | EDGAR |
| 2025-01-14 | SLS | Grant (A) | +500,900 | $0 | EDGAR |
| 2024-12-05 | SLS | Other (J) | −28,289 | -$32.0K | EDGAR |
| 2024-01-25 | SLS | Grant (A) | +159,000 | $0 | EDGAR |
| 2023-12-08 | SLS | Other (J) | −12,268 | -$13.2K | EDGAR |
| 2023-02-03 | SLS | Grant (A) | +58,000 | $0 | EDGAR |
| 2022-12-05 | SLS | Sell (S) | −6,494 | -$16.9K | EDGAR |
| 2022-02-01 | SLS | Grant (A) | +44,000 | $0 | EDGAR |
| 2021-12-03 | SLS | — | — | $0 | EDGAR |
| 2021-12-03 | SLS | Sell (S) | −2,120 | -$13.3K | EDGAR |